Menu

Annual Report 2015

STRONGER

To our Shareholders

“Today, Merck is better positioned than ever before. We can be proud of what Merck is today: a leading science and technology company whose ideas and products can really make a difference in the world. With our three business sectors Healthcare, Life Science and Performance Materials, we are not only successful, but also improve the lives of patients, customers and partners all over the world.”

Karl-Ludwig Kley
Chairman of the Executive Board

More

Magazine

A CLEAR
VIEW

Merck is working to develop future-oriented products, such as an ingenious artificial eye lens in which liquid crystal technology is used.

More

READY FOR
PRINTING

OLED displays offer captivating advantages, whether for smartphones or large televisions. With innovative printing processes, Merck wants to play a pioneering role in this field.

More

PROGRESS

Immuno-oncological therapies represent a new era in cancer treatment. Merck and Pfizer aim to unlock the potential of this area of research through a strategic alliance.

More

AWARE
NESS

With its Capacity Advancement Program, Merck aims to strengthen its education and prevention efforts among people living in developing countries. The focus is on diabetes, cancer and fertility treatment.

More

GROWTH

Having completed the acquisition of Sigma-Aldrich, Merck is now one of the leading players in the global life science industry – and also has a superb e-commerce platform.

More

A CLEAR
VIEW

Merck is working to develop future-oriented products, such as an ingenious artificial eye lens in which liquid crystal technology is used.

More

READY FOR
PRINTING

OLED displays offer captivating advantages, whether for smartphones or large televisions. With innovative printing processes, Merck wants to play a pioneering role in this field.

More

PROGRESS

Immuno-oncological therapies represent a new era in cancer treatment. Merck and Pfizer aim to unlock the potential of this area of research through a strategic alliance.

More

AWARE
NESS

With its Capacity Advancement Program, Merck aims to strengthen its education and prevention efforts among people living in developing countries. The focus is on diabetes, cancer and fertility treatment.

More

GROWTH

Having completed the acquisition of Sigma-Aldrich, Merck is now one of the leading players in the global life science industry – and also has a superb e-commerce platform.

More